Insight Molecular Diagnostics Inc.IMDXEarnings & Financial Report
Nasdaq · Health Care · In Vitro & In Vivo Diagnostic Substances
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Broadwood Partners, L.P. | 37.60% | 5.1M | — | 2024-04-15 |
| Nos. of | 9.10% | 754.3K | — | 2024-02-14 |
| Bio-Rad Laboratories, Inc. | 8.97% | 1.5M | flat | 2024-10-24 |
| S OR | 4.57% | 616.6K | ▼ -3.88pp | 2024-11-14 |
Insider Transactions
Net 90d: +$3.65M · buys $3.65M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-20 | L.P. BROADWOOD PARTNERS | 10% Owner | Buy (open market) | 40.7K | $3.88 | $158.0K |
| 2026-04-20 | L.P. BROADWOOD PARTNERS | 10% Owner | Buy (open market) | 0 | $0.00 | $0 |
| 2026-04-17 | L.P. BROADWOOD PARTNERS | 10% Owner | Buy (open market) | 40.1K | $3.57 | $143.3K |
| 2026-04-17 | L.P. BROADWOOD PARTNERS | 10% Owner | Buy (open market) | 0 | $0.00 | $0 |
| 2026-04-16 | L.P. BROADWOOD PARTNERS | 10% Owner | Buy (open market) | 102.1K | $3.45 | $351.7K |
| 2026-04-16 | L.P. BROADWOOD PARTNERS | 10% Owner | Buy (open market) | 0 | $0.00 | $0 |
| 2026-03-26 | James Andrea S. | Chief Financial Officer | Option exercise | 28.3K | — | — |
| 2026-03-26 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Option exercise | 6.3K | — | — |
| 2026-03-26 | Josh Riggs | CEO and President | Option exercise | 47.2K | — | — |
| 2026-02-10 | L.P. BROADWOOD PARTNERS | 10% Owner | Buy (open market) | 521.7K | $5.75 | $3.00M |
1–10 of 11
Page 1 / 2